85 results
8-K
EX-99.1
SYRE
Spyre Therapeutics Inc.
9 May 24
Spyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:11pm
://spyre.com.
Follow Spyre Therapeutics on social media: @spyretx and LinkedIn.
Safe Harbor / Forward Looking Statements
This press release contains
POS AM
SYRE
Spyre Therapeutics Inc.
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
, economic, political, and social conditions and the uncertainty around China’s relationship with other governments, such as the United States and the UK
424B3
SYRE
Spyre Therapeutics Inc.
18 Mar 24
Prospectus supplement
4:06pm
and in their possession or control: (i) a natural person’s name, street address, telephone number, e-mail address, photograph, social security number or other tax
8-K
EX-10.1
SYRE
Spyre Therapeutics Inc.
18 Mar 24
Spyre Therapeutics Announces $180 Million Private Placement
8:31am
, street address, telephone number, e-mail address, photograph, social security number or other tax identification number, driver’s license number
POS AM
g53o 85x9gk4
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
POS AM
oznot dmt7xihn4u9
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
8-K
EX-99.1
i4rlcvnbn1j7czpyya
29 Feb 24
Spyre Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
4:14pm
424B3
6v3athmb
6 Feb 24
Prospectus supplement
9:37pm
8-K
EX-14.1
4re8uc zn4njnr
5 Feb 24
Entry into a Material Definitive Agreement
7:36am
S-8
EX-99.1
kih16mggss92fgeh
22 Dec 23
Registration of securities for employees
5:00pm
S-8
EX-99.2
a3e3vw933kerh
22 Dec 23
Registration of securities for employees
5:00pm